Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2082221 | Drug Discovery Today: Disease Models | 2010 | 5 Pages |
Abstract
Mutations of the bone morphogenetic protein type II receptor (BMPR2) gene were identified in the patients with pulmonary hypertension a decade ago. However, the pathogenesis of the disease remains to be elucidated because of the complex roles of additional genetic and/or environmental factors in the onset of the disease. Genetically modified mice for the BMPR2 gene were reported in the past several years. These findings reveal a crucial role of the BMPR2 gene in the development of pulmonary hypertension.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
H. Beppu,